New Approvals for TMS
The Carlat Psychiatry Report, Volume 16, Number 11 & 12, November 2018
Talia Puzantian, PharmD, BCPP
Chris Aiken, MD
Drs. Puzantian and Aiken have disclosed that they have no relevant financial or other interests in any commercial companies pertaining to this educational activity.
We know that transcranial magnetic stimulation (TMS) works for treatment-resistant depression (TRD), but one disadvantage is the length of the treatment sessions.